Puma Biotechnology, Inc. (PBYI) NASDAQ
6.98
-0.14(-1.97%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 297.57M |
| Enterprise Value | 296.48M |
| P/E Ratio | 14.55 |
| PEG Ratio | -0.42 |
| Price/Sales Ratio | 1.56 |
| Price/Book Ratio | 2.76 |
| Enterprise/Revenue | 1.47 |
| Enterprise/EBITDA | 7.65 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.11 |
| Operating Margin | 0.13 |
Management Effectiveness
| Return On Assets | 0.13 |
| Return On Equity | 0.2 |
Income Statement
| Revenue | 228.37M |
| Revenue/Share | 4.47 |
| Gross Profit | 170.21M |
| EBITDA | 53.34M |
| Net Income | 31.11M |
| Diluted EPS | 0.61 |
Balance Sheet
| Total Cash | 101.6M |
| Total Cash/Share | 2 |
| Total Debt | 15.95M |
| Total Debt/Equity | 0.12 |
| Current Ratio | 2.38 |
| Book Value Per Share | 2.53 |
Price History
| 52-Week Change | 112.16 |
| 52-Week High | 7.9 |
| 52-Week Low | 3.03 |
| Moving Average 50 Days | 7.13 |
| Moving Average 200 Days | 6.01 |
Statistics
| Average Volume | 283,676 |
| Shares Outstanding | 50.9M |
| % Held by Institutions | 75.7 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
